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A B S T R A C T
Soybean is recognized as a commonly allergenic food, but the identity of important allergens is not well studied.
Recently, some global regulatory agencies started requiring quantitative analysis of individual allergens, in-
cluding unproven allergens, as part of the risk assessment for genetically engineered (GE) soybeans. We sought
to identify soybean proteins that bind IgE from any of 10 individual soybean-sensitized subjects. Soybean IgE
binding proteins were identiﬁed by 2-DE immunoblots using sera from four soy-allergic and plasma from six soy-
sensitized human subjects. Corresponding spots were excised from stained gels, digested, and analyzed using a
quadrupole TOF Synapt G2-S tandem mass spectrometer. Results showed the major IgE binding proteins were
subunits of either β-conglycinin (Gly m 5) or glycinin (Gly m 6). Soybean Kunitz trypsin inhibitor (SKTI) was a
signiﬁcant IgE binding protein for four subjects. Soybean agglutinin, seed biotinylated protein (SBP) of 65 kDa,
late embryogenesis protein (LEP), and sucrose-binding protein were identiﬁed as IgE binding only for soy-
sensitized subjects. We conclude that the major soybean allergens are isoforms of Gly m 5, Gly m 6, and possibly
SKTI and that requirements for quantitative measurement of proteins that are not clear allergens is not relevant
to safety.
1. Introduction
Soybean (Glycine max [L.] Merr.) is a nutritionally important source
of edible oil and protein for human food and animal feed. However,
soybean is recognized as one of the common allergenic food sources
requiring food allergen labeling (“Big Eight” in the U.S. and among the
top 14 in the European Union). Eight foods and food groups are thought
to account for up to 90% of IgE mediated food allergic reactions in the
U.S. (Taylor and Heﬂe, 2001). Soybean food allergy is relatively
common in infants and young children in the U.S. due to the exposure
to soy-based formula for those with cow's milk allergy (Zeiger et al.,
1999). However, most children outgrow their soybean food allergy by
the age of 10 years (Savage et al., 2010), although a few individuals
become sensitized and/or allergic as adults.
The precise prevalence of soybean food allergy in the general po-
pulation is unknown. An accurate estimate of soybean allergy would
require studies of general populations in diﬀerent countries and
evaluation of various age groups using clinical demonstration of ad-
verse reactions to soybean products. Preferably the studies would be
double-blind, placebo-controlled food challenges (DBPCFC) to rule out
false-positive reactions. Other clinical tests that could be useful to de-
monstrate an IgE-mediated mechanism for the adverse reactions can be
performed either by skin prick tests (SPT) or by determination of soy-
bean protein speciﬁc IgE levels in serum (Taylor et al., 2015). A number
of publications appear to over-estimate the prevalence of soybean al-
lergy. Most were conducted on referred allergic populations or atopic
populations without conﬁrmation of clinical reactions. A study in Italy
estimated that 6.1% (8/131) of atopic children have soybean allergy
(Magnolﬁ et al., 1996). A second study in Italy evaluated 505 allergic
children with symptoms of atopic dermatitis, cow's milk allergy, urti-
caria, asthma, rhinitis following reported consumption of soybean and
found that 6% (31/505) had positive by SPT to soybean, but only 6 of
those 31 children were positive when tested by DBPCFC. Thus, a more
accurate estimate of allergic-children in Italy having true soybean food
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allergy is 1.2% (6/505) (Bruno et al., 1997). Additional studies have
been conducted by questionnaire, relying on subjects' self-reported al-
lergy-like symptoms related to soybean consumption, which likely leads
to an overestimation of prevalence (Gupta et al., 2011; McGowan and
Keet, 2013). A recent systematic review summarizing 40 studies on the
worldwide prevalence of soybean allergy and concluded that 0.27% of
the general population likely have soybean allergy (Katz et al., 2014).
Over 90% of soybeans grown in the U.S. are genetically engineered
(GE) varieties that are bred into many genetic lines (Fernandez-Cornejo
et al., 2014). A number of independent scientiﬁc studies have reviewed
the evidence regarding the risks of GE crops. These studies conclude
that based on scientiﬁc evidence, commercialized GE crops are safe for
human consumption and the environment (Delaney et al., 2018;
Domingo, 2007; Goodman et al., 2013; Hoﬀ et al., 2007; Kuiper et al.,
2001; Sten et al., 2004). Despite extensive research, some scientists and
a few non-governmental organizations (NGOs) debate the safety of GE
crops, particularly in countries of the European Union. The majority of
GE crops are grown in the U.S., Brazil, Argentina and Canada (http://
www.isaaa.org/gmapprovaldatabase/default.asp). Some governments
that collectively represent over 50% of the global population (e.g.,
India, China, Bangladesh, Indonesia, Pakistan, the Philippines, Ethiopia
and Egypt) have approved only a few GE crops for cultivation such as
cotton, even though many studies have demonstrated the GE crops are
not substantially diﬀerent from commonly cultivated non-GE varieties
(Delaney et al., 2018). Most countries allow importation of commod-
ities from speciﬁc GE varieties for use in food, feed or industrial pro-
ducts. Use and cultivation in almost all countries require safety eva-
luations with most countries following guidelines of the CODEX
Alimentarius Commission (Codex, 2009).
The recently revised European Commission regulation 503/2013
requires mandatory quantitative measurement of endogenous allergens
as part of the compositional analysis in the risk assessment for GE
soybean, taking into account recommendations of OECD (EU, 2013).
The OECD document on soybean allergens lists 15 proteins designated
as “allergens” as shown in Table 20 of the OECD recommendations for
soybean (OECD, 2012), which was derived primarily from one litera-
ture review by L'Hocine and Boye (L'Hocine and Boye, 2007). This re-
quirement has been questioned and subjected to criticism because
several of the listed soybean proteins are only putative allergens (e.g.,
Gly m Bd 30 K, Gly m Bd 28 K, lectin, lipoxygenase) or are poorly
characterized proteins (e.g., no amino acid sequences for the 39 kDa
and 50 kDa and P22-25 proteins) (Ladics et al., 2014). A review by Selb
et al., in 2017 discusses the evidence and the lack of evidence for the
relevance of some proteins in the OECD list (Selb et al., 2017). There
are no studies demonstrating that individual proteins cause objective
reactions based on blinded challenges in allergic consumers. In two
studies, IgE reactivity of soybean allergic individual's sera with the
single soybean allergens Gly m 5 and Gly m 6 was found to be asso-
ciated with clinical reactions caused by soybean (Holzhauser et al.,
2009; Ito et al., 2011). In addition, these are very abundant proteins. In
populations of northern Europe, Gly m 4 is the most commonly re-
cognized proteins using serum IgE from clinically allergic adult sub-
jects, while more proteins are often recognized in extracts of soybean
(Mittag et al., 2004). We recently showed that individual soybean al-
lergic or soybean sensitized subjects show individual IgE binding pat-
terns using reducing and non-reducing one-dimensional gel chromato-
graphy and immunoblotting and individual patterns in total IgE binding
to proteins in non-denaturing extracts using extracts of multiple soy-
bean lines grown in two or three locations (Lu et al., 2018). Those re-
sults led us to investigate the individual proteins bound by IgE using
multiple subjects.
In recent years, the combination of 2-DE immunoblots coupled with
mass spectrometry of isolated protein spots has become a powerful tool
to identify potential allergens from various sources (Batista et al., 2007;
Choopong et al., 2016; Chuang et al., 2010; Nakamura and Teshima,
2013). The aim of this study was to identify the IgE binding proteins
from soybean using sera from soy-allergic subjects and plasma from
soy-sensitized subjects. The identiﬁcation of IgE binding proteins is
important to achieve a better understanding of soybean allergens for
soybean allergy diagnosis, identiﬁcation of possible immunotherapy
reagents and for risk assessment and risk management of foods. A
second potential outcome of this study was to verify the relevance of
proteins listed by the OECD as being soybean allergens and to question
the relevance of quantitation for the speciﬁed 15 “allergens” to the risk
assessment of GE soybean.
2. Material and methods
2.1. Soybean protein extraction
Raw, full-fat ﬂour samples of a non-GE soybean line (Glycine max)
were produced from soybeans grown in multiple locations by Pioneer
Hi-Bred International, Inc. Protein extraction was performed by the
trichloroacetic acid/acetone method described by Natarajan et al., in
2005 (Natarajan et al., 2005), and modiﬁed as described previously
(Panda et al., 2013) using 8M urea and 2% 3-((3-cholamidopropyl)
dimethylammonio)-1-propanesulfonate (CHAPS) to extract the protein.
The protein content of clariﬁed extracts was determined by Bradford
assay (Bio-Rad) (Ramagli, 1999).
2.2. Soy-allergic human sera and soy-sensitized human plasma
Samples from ten adult human subjects were provided from two
sources: the University Hospital Zürick, Switzerland provided sera from
four soy-allergic patients and PlasmaLab International, Everett, WA,
U.S. (www.plasmalab.com) provided plasma samples from six soy-
sensitized subjects. The four soy-allergic patients had a history of al-
lergic reactions to consuming soybean and their soybean allergies were
conﬁrmed by DBPCFC. The six soy-sensitized patients had only self-
reported allergies to soybean and displayed detectable ImmunoCAP®
scores to soybean. Clinical symptoms of allergy and sensitivity to soy-
bean and ImmunoCAP® scores are listed in Table 1. Sera from ﬁve in-
dividuals without reported allergy to soybean who did not experience
symptoms in an open food challenge with soy milk and with very low
soybean-speciﬁc IgE (< 0.35 kU/L ImmunoCAP® value) were used as
negative controls. It is important to note that soybean allergy occurs
mostly in young children who become tolerant by 10 years of age and
Table 1
Soy-allergic human sera and soy-sensitized plasma. Human subject selec-
tion was based on clinical history or self-reported history related to consump-
tion of soybean. ImmunoCAP® results are shown, and n/a means not available,
OAS is oral allergy syndrome.
Subject ID ImmunoCAP® (kU/l) Symptoms as reported by history
Soy Gly m 4 Total IgE
Soy-allergic human sera
Neb-4 2.06 n/a n/a OAS, nausea, emesis
Neb-5 9.23 n/a n/a OAS, dyspnea, hypotension
Neb-7 < 0.35 26.2 n/a OAS
Neb-8 6.42 1.58 n/a OAS, nausea, emesis, diarrhea,
gastrointestinal pain
Soy-sensitized human plasma
9735-RE 5.00 n/a > 5000 Anaphylaxis to peanut. Soybean
causes sore throat, itchy mouth, and
queasy stomach.
19392-CS 71.60 n/a 896 Angioedema, vomiting
20197-BH 3.00 n/a n/a Itchy throat with nuts and raw
vegetables
23508-JK 6.7 n/a n/a Multiple allergies, not well-deﬁned
24924-LH 13 n/a n/a Multiple allergies, not well-deﬁned
26730-AB 5 n/a n/a Anaphylaxis to peanuts, dyspnea,
angioedema, hives
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only rarely in adults. Thus, it is diﬃcult to obtain samples from a large
number of soybean allergic subjects. Individual sera and plasma were
collected previously from subjects who provided voluntary consent for
studies with speciﬁc institutional review board approval (Zürich) or by
a U.S. Food and Drug Administration licensed facility (PlasmaLab).
2.3. Two dimensional gel electrophoresis (2-DE) and immunoblotting
Soybean extracts representing 30 μg of protein were diluted to a
ﬁnal volume of 125 μl of rehydration buﬀer (8M urea, 2% CHAPS,
50mM dithiothreitol (DTT) and 0.5% ampholyte pH 3–10) for each 2-
DE separation. The 125 μl sample was applied to a non-linear 7 cm
immobilized pH gradient strip pH 3–10. Active rehydration was per-
formed at 50 V of direct current (vdc), 20 °C for 12 h, followed by se-
paration with rapid ramping up to 250 vdc for 15min, gradual ramping
up to 4000 vdc for 2 h, then a limit of 4000 vdc which was continued
until 37,500 integrated volt x hours was obtained (Panda et al., 2013).
The strips were reduced with DTT and alkylated with iodoacetamide
equilibration buﬀer (Bio-Rad). The second dimension gel electrophor-
esis separation was completed using NuPAGE® Novex 4–12% Bis-Tris
ZOOM® gels (Invitrogen). A representative gel was ﬁxed and stained
with EZBlue™ Gel stain (Sigma).
Proteins from identical gels were transferred to polyvinylidene di-
ﬂuoride membranes for immunoblots. The membranes were dried
completely, ﬁxed and stained with SYPRO Ruby protein blot stain (Bio-
Rad) before blocking. The images of stained membranes were taken
with a Gel Logic 440 image station (Kodak), then membranes were
rewet with methanol and blocked with 5% non-fat dry milk. Individual
soybean allergic or non-allergic sera were diluted based on prior
knowledge of soybean-speciﬁc IgE (1: 5, 1:10 or 1:20, v:v) and in-
cubated with the membranes overnight. Unbound IgE was removed by
four washes with 0.5% Tween in PBS. Bound IgE was detected using
monoclonal anti-human IgE (Southern Biotech) diluted 1:1,000, then
washed to remove unbound detection antibody. Bound anti-IgE was
detected with SuperSignal West Dura chemiluminescent substrate
(Thermo Fisher Scientiﬁc). Immunoblot images were captured in the
Kodak Gel Logic 440, without light and without a ﬁlter at the same
condition focal length as the images of SYPRO stained membranes.
2.4. Protein spots sampling and trypsin digestion
To locate the position of IgE binding proteins, the SYPRO stained
membranes and the immunoblot images were overlapped and com-
pared. After the IgE binding spots were identiﬁed for all 10 human
samples, corresponding to EZBlue stained protein spots, the spots were
excised from the 2-DE gels based on apparent MW and pI, placed in
individual microfuge tubes and then digested (Natarajan et al., 2006;
Shevchenko et al., 1996). Brieﬂy, the protein samples were washed
with 100mM ammonium bicarbonate, reduced with 10mM DTT, al-
kylated with 55mM iodoacetamide, washed twice with 100mM am-
monium bicarbonate, and digested in situ with 10 ng/μl trypsin (Pro-
mega). Peptides were extracted with two 60 μl aliquots of 1:1
acetonitrile:water containing 1% formic acid. These extracts were dried
using a SpeedVac and then reconstituted in 12 μl of 0.1% formic acid for
application in the liquid chromatography-tandem mass spectrometry
(LC-MS/MS) system.
2.5. LC-MS/MS
Formic-acid reconstituted extract solutions (4 μl) were injected onto
a trapping column (300 μm x 1mm) in line with a 75 μm x 150mm
1.7 μm BEH130 C18 reversed phase LC column (Waters). Peptides of
each sample were eluted from the column using 0.1% formic acid (A)/
95% acetonitrile: 0.1% formic acid (B) gradient at a ﬂow rate of 270 nl/
min. Gradients were developed with the following time proﬁle: 0 min
0% B, 5min 5% B, 35min 35% B, 40min 45% B, 42min 60% B, 45min
90% B, 48min 95% B, and 50min 5% B. Eluted peptides were analyzed
using a quadrupole TOF Synapt G2-S MS/MS spectrometer (Micromass
Waters) with electrospray ionization. Analyses were performed using
data-dependent acquisition with lock mass correction. The MS/MS data
were processed with Distiller software (Matrix Science) to produce peak
lists for database searching using MASCOT (Matrix Science). Data were
searched against the National Center for Biotechnology (NCBI) non-
redundant database in 2014, with the search restricted to proteins in
green plants (Viridiplantae). The following search parameters were used:
mass accuracy 0.1 Da, enzyme speciﬁcity trypsin, ﬁxed carbamido-
methylated modiﬁcation, and variable modiﬁcation oxidized methio-
nine. Protein identiﬁcations were based on random probability scores
with a minimum value of 25.
2.6. Identiﬁcation of putative allergenic proteins using MASCOT data
The scoring of MASCOT incorporated a probability-based im-
plementation of the molecular weight search (MOWSE) algorithm with
the formula: MOWSE score=−10×Log (P), where P is the prob-
ability that the observed match is a random event. A random match will
have a high probability (P), therefore indicated by a low MOWSE score,
whereas a valid match will have a low probability as indicated by a
high MOWSE score (Weber et al., 2006). MASCOT ranks the quality of
the peptide matches and sums the scores of the detected peptides to
calculate a total protein MOWSE score with the highest scoring proteins
representing the most likely protein detected in the gel spot. The top
matches of proteins were selected based on the highest ranking of the
protein MOWSE score.
3. Results
3.1. 2-DE gel patterns and immunoblots
The stained 2-DE gel image of the soybean extract is shown in Fig. 1
(A). As is typical for a soybean seed extract, most of the proteins lo-
calize in the acidic pI range of between 3 and 7, and individual proteins
were between 10 and 90 kDa mass. Some of the proteins were identiﬁed
only in single spots, and others occurred in series of spots of approxi-
mately the same MW but at diﬀerent pI values.
The IgE binding from four soy-allergic and six soy-sensitized sub-
jects showed clearly distinct patterns to soybean proteins, indicating the
diversity of individual responses to soybean proteins (Fig. 2). However,
some common immunoreactive proteins were detected. The numbering
of the IgE binding spots in Fig. 2 corresponds to the spot numbers in
Fig. 1 (B). Collectively, 36 IgE binding spots that were the primary
targets of IgE from the 10 human subjects’ sera and plasma samples
were labeled on the stained gel image in Fig. 1 (B). The plasma from
non-soybean allergic individuals used as negative controls, showed no
IgE binding to any protein in the soybean extracts (data not shown).
3.2. Protein identities analyzed by LC-MS/MS
The IgE binding spots labeled on the gel in Fig. 1 (B) were analyzed
by mass spectrometry. The MS/MS data of the IgE binding proteins is
shown in Table 2. Only the identities of the highest protein MOWSE
score hits are listed. Because LC-MS/MS almost never detects full-length
coverage of any protein, there is some uncertainty of the complete se-
quences of the proteins. In addition, often peptides from more than one
protein can be identiﬁed for an individual spot. The results are dis-
cussed in the context of individual matches and potential biological
meaning. The numbers of peptides matched and percentage of coverage
also indicate a high degree of conﬁdence that the proteins identities are
accurate.
As shown in Table 2, the isoforms of the two abundant seed storage
proteins β-conglycinin (Gly m 5, three subunits) and glycinin (Gly m 6,
ﬁve subunits) were located at several diﬀerent positions (diﬀerent MW
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and pI) on the 2-DE gels. For example, the α subunit of β-conglycinin
was identiﬁed at spots 1, 3, 6, and 16; the α’ subunit was identiﬁed at
spots 2 and 4; and the β subunit of β-conglycinin was identiﬁed at spots
14a, 14b, 15a, 15b, 15c, 17c, and 18b. Glycinin G1 subunit was iden-
tiﬁed at spots 8c, 8d, 19, and 20; glycinin G2 subunit was identiﬁed at
spots 8a, 8b; and glycinin G4 subunit was identiﬁed at spots 7 and 9.
The occurrence of multiple positions might be due to post-translational
modiﬁcations of protein or peptide cross-linking to other proteins or
peptides (Green-Church et al., 2008). In certain, the protein spots re-
solve as a series of spots that are likely to be minor variants of the same
protein, i.e., either minor isoform diﬀerences or diﬀerences created by
post-translational modiﬁcation or post-extraction chemical changes
(Kischkel et al., 2000; Machamer and Cresswell, 1982). For example,
spots 11a, 11b, 11c are seed biotinylated protein (SBP) 65 kDa; spots
12a, 12b are sucrose-binding protein; spots 12c, 12d are late embry-
ogenesis protein (LEP); and spots 14a, 14b and 15a, 15b, 15c represent
β-conglycinin, β subunits.
It was determined that multiple signiﬁcant MOWSE hits (diﬀerent
proteins) commonly occurred for one spot. Those are proteins that have
similar MW and pI values and thus co-migrate to the same position on
the 2-DE gel. For instance, for spot 1, the highest MOWSE scoring hit
shows 56% sequence coverage of a β-conglycinin, α subunit (precursor)
sequence composed of 605 amino acids; the second MOWSE scoring hit
shows 40% sequence coverage of a β-conglycinin, α subunit sequence
composed of 623 amino acids; the third scoring hit shows 44% se-
quence coverage of a β-conglycinin, α’ subunit sequence composed of
559 amino acids. Yet, only the top signiﬁcant hits are reported in
Table 2. It must be noted that the identiﬁcation of multiple proteins in a
single spot correlating to an IgE binding spot does not necessarily mean
they all bind IgE or are putative allergens. Serum IgE binding tests with
individual puriﬁed proteins would be required to determine the speci-
ﬁcity of binding with certainty. Clinical tests with individual pure
Fig. 1. Separation of soybean proteins by 2-DE shown by Coomassie staining (A) and spot designation where of stained spots that correspond to IgE
binding for at least one of the ten subjects (B). Each spot was excised and placed in a separate microfuge tube for digestion by trypsin and injection in LC-MS/MS.
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proteins would be needed to demonstrate clinically relevant im-
munoreactivity by SPT, or by oral food challenges.
3.3. Frequency of IgE positive sera/plasma to individual soybean allergens
The identities of the IgE binding proteins in serum and plasma
samples for each soybean allergic subject are summarized in Table 3.
Six out of the ten soy-allergic or soy-sensitized subjects had IgE binding
to one or more of the β-conglycinin subunits (Gly m 5). Eight out of the
ten subjects had IgE binding to one or more of the glycinin subunits
(Gly m 6). Only subject Neb-7 did not show IgE binding to either one or
more subunits of Gly m 5 or Gly m 6. That subject's IgE only bound to
SKTI. Three of the four clinically conﬁrmed soy-allergic subjects' sera
showed IgE binding to SKTI, and one of the soybean sensitized subjects
displayed similar binding response in plasma to SKTI. Two out of the
ten subjects showed IgE binding to soybean agglutinin (spot 10). Three
other proteins were only bound by IgE from the soy-sensitized subjects
and those included SBP 65 kDa (spots 11a, 11b and 11c), LEP (spots
12c, 12d), and sucrose-binding protein (spots 12a, 12b).
4. Discussion
Most of the IgE binding proteins identiﬁed by the ten soy-allergic or
soy-sensitized subjects were subunits of either β-conglycinin (Gly m 5)
or glycinin (Gly m 6), which are the abundant seed storage proteins that
have been identiﬁed by others as major soybean allergens (Holzhauser
et al., 2009). Beta-conglycinin and glycinin subunits make up 30% and
40% to the total seed protein, respectively. The β-conglycinin is a tri-
meric protein composed of three subunits in various mixtures of α
(∼72 kDa, pI of 5.18), α’ (∼76 kDa, pI of 4.90), and β (∼53 kDa, pI of
5.66–6.00) subunits (Krishnan et al., 2009). The α subunit of β-con-
glycinin was called Gly m Bd 60 K in earlier references (Ogawa et al.,
2000). Glycinin is a hexameric protein that is an assembly by ﬁve dif-
ferent subunits: G1 (A1aB1b, 53.6 kDa), G2 (A2B1a, 52.4 kDa), G3
Fig. 2. Identiﬁcation of soybean IgE binding proteins by 2-DE immunoblots for all ten subjects. Four subjects (Neb-4, Neb-5, Neb-7 and Neb-8) were clinically
diagnosed with allergy to soybean, in Switzerland. The last six subjects were self-reported as allergic to soybean and their plasma tested positive with IgE binding to
soybean by ImmunoCAP® by PlasmaLab in Everette, WA. Spot numbers correspond to stained proteins identiﬁed by LC-MS/MS.
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(A1bB2, 52.2 kDa), G4 (A5A4B3, 61.2 kDa), and G5 (A3B4, 55.4 kDa).
Each individual glycinin protein is translated as a single protein that is
cleaved into an acidic and a basic peptide chain, linked by a disulﬁde
bond (Prak et al., 2005). Our results are consistent with previous
ﬁndings that all subunits of β-conglycinin and glycinin bound IgE in
sera from some DBPCFC positive soybean allergic subjects (Holzhauser
et al., 2009). In addition, the levels of IgE responses to β-conglycinin
and glycinin were associated with severe clinical reactions caused by
soybean (Ito et al., 2011). The results of this study conﬁrmed that β-
conglycinin and glycinin are the two major clinically important soy-
bean allergens in the soy-allergic and soy-sensitive population from the
U.S. and Switzerland tested in this study.
Soybean Kunitz trypsin inhibitor was bound by IgE from three of the
four clinically conﬁrmed soy-allergic subjects, which indicates SKTI
Table 2
Identiﬁcation of IgE binding proteins by LC-MS/MS. Spot numbers correspond to Fig. 1B. No signiﬁcant identity matches were found for spots 14c and 18a.
Theoretical mass of the individual proteins and the expected pI values are shown along with the MOWSE score, number of peptide matches to the identiﬁed protein
accession and the percent coverage of identiﬁed protein sequences is shown for each spot.
Spot* NCBI Accession GI# Protein Type Theoretical
Mass (Da)/pI
Protein MOWSE
Score
No. Peptides Matched Sequence Coverage (%)
1 P13916.2 β-conglycinin, α 70535/5.07 3173 107 56
2 BAA74452.2 β-conglycinin, α′ 65160/5.23 3127 116 62
3 P13916.2 β-conglycinin, α 70535/5.07 1320 33 32
4 BAA74452.2 β-conglycinin, α′ 65160/5.23 2170 68 51
5 CAA55977.1 Glycinin G5 58608/5.52 1555 48 40
6 P13916.2 β-conglycinin, α 70535/5.07 1656 49 38
7 CAA37044.1 Glycinin G4 64351/5.21 1559 36 28
8a P04405.2 Glycinin G2 54927/5.46 4416 76 44
8b P04405.2 Glycinin G2 56299/5.46 2180 37 42
8c P04776.2 Glycinin G1 56299/5.89 2075 40 50
8d 1FXZ_A Glycinin G1 54047/5.78 1254 42 47
9 CAA37044.1 Glycinin G4 64351/5.78 1371 29 27
10 2SBA_A Soybean agglutinin 27555/5.21 1200 41 49
11a Q39846.1 SBP of 65 kDa 67894/6.1 587 10 22
11b Q39846.1 SBP of 65 kDa 67894/6.1 2281 47 53
11c Q39846.1 SBP of 65 kDa 67894/6.1 2919 62 65
12a Q04672.1 Sucrose-binding protein 60884/6.42 833 14 24
12b Q04672.1 Sucrose-binding protein 60884/6.42 877 15 29
12c AAA33985.1 LEP 50613/6.33 1436 30 49
12d AAA33985.1 LEP 50613/6.33 189 3 11
13 1BA7_A SKTI 20310/4.61 974 45 88
14a 1IPJ_A β-conglycinin, β 47879/5.67 1228 23 45
14b 1IPJ_A β-conglycinin, β 47879/5.67 485 10 31
15a 1IPJ_A β-conglycinin, β 47879/5.67 1906 42 56
15b BAD98463.1 β-conglycinin, β 48358/5.67 1980 51 56
15c 1IPJ_A β-conglycinin, β 47879/5.67 2055 54 56
16 P13916.2 β-conglycinin, α 70535/5.07 1723 42 37
17a ACU18647.1 Unknown protein 43082/6.28 1723 45 81
17b ACU18647.1 Unknown protein 43082/6.28 912 19 61
17c 1IPK_A β-conglycinin, β 47947/5.67 759 14 37
18b 1IPJ_A β-conglycinin, β 47879/5.67 1490 35 50
19 P04776.2 Glycinin G1 56299/5.89 980 40 33
20 P04776.2 Glycinin G1 56299/5.89 1035 65 33
Table 3
Summary of the identities of IgE binding soybean proteins with all ten subjects. Numbers represent spots of the stained gel as shown in Fig. 1B. Only subject
Neb-7 did not show IgE binding to either one or more β-conglycinin subunits (Gly m 5) or glycinin subunit (Gly m 6). That subject's IgE only bound to SKTI.
Subjects
Proteins Spot Numbers1
Neb-4 Neb-5 Neb-7 Neb-8 9735-RE 19392-CS 20197-BH 23508-JK 24924-LH 26730-AB
Gly m 5 (β-conglycinin)
β-conglycinin, α 1 1, 3, 6, 16 1, 3, 16 1 1, 6, 16
β-conglycinin, α′ 2 2, 4 4
β-conglycinin, β 15a,b,c, 18b, 17c 15a,b,c,
18b
14a,b, 17c 15a,b,c, 18b
Gly m 6 (Glycinin)
Glycinin G1 20 8c,d 8c,d, 19, 20 19 19, 20
Glycinin G2 8a,b 8a 8a,b 8b 8a,b 8a,b 8a,b
Glycinin G4 9 7 7
Glycinin G5 5 5
Other possible soybean allergens
SKTI 13 13 13 13
Soybean agglutinin 10 10
SBP of 65 kDa 11a,b,c
LEP 12c,d
Sucrose-binding protein 12a,b
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might be an important food allergen for soy-allergic patients. SKTI ac-
counts for 4–7% of the total extractable protein in soybean with a MW
of ∼22 kDa and pI of 4.5 (Taylor et al., 2015). The SKTI protein has
previously been reported to be an inhalation allergen among 14 bakers
suﬀering from respiratory symptoms to soybean (Baur et al., 1996). In
one study, inhalation of puriﬁed SKTI caused positive clinical reactivity
in two sensitized bakers (Quirce et al., 2002). Allergic reactions caused
by ingestion of SKTI have only been conﬁrmed in one individual, who
was exposed to SKTI occupationally (Moroz and Yang, 1980). SKTI is
not included in the World Health Organization and International Union
of Immunological Society (WHO/IUIS) database, and the food aller-
genicity of SKTI needs to be investigated further.
Soybean agglutinin was identiﬁed as an IgE binding protein with
sera from one soy-allergic sera and from plasma of one soy-sensitized
subject in this study. Soybean agglutinin is also known as a soy lectin
that is an anti-nutritional factor in soybean. It accounts for approxi-
mately 10% of the total protein (Maria John et al., 2017; Natarajan
et al., 2009). Soybean agglutinin has a MW of approximately 120 kDa
and pI of 5.8. It is composed of four identical subunits of 30 kDa. There
is a carbohydrate moiety bound to the agglutinin by an N-acet-
ylglucosaminyl linkage to asparagine (Lotan et al., 1974). Lectins are
glycoproteins found in plant seeds, which have been shown to have
non-speciﬁc IgE binding to carbohydrate moieties inducing allergy-like
symptoms (Shibasaki et al., 1992). It is not clear whether the aggluti-
nins can elicit allergic reactions or can stimulate basophils to release
histamine. However, peanut agglutinin was identiﬁed as a speciﬁc IgE
binding protein from peanut allergic patients (Burks et al., 1994). A few
review papers list soybean agglutinin as a soybean allergen based on
IgE binding (L'Hocine and Boye, 2007; Wang et al., 2014; Wilson et al.,
2005), but little is known about the allergenicity of soybean agglutinin.
Batista et al. (2007) and our study identiﬁed soybean agglutinin as a
potential soybean allergen using the combination of 2-DE immunoblot
and LC-MS/MS techniques. However, further studies would be needed
to verify the allergenicity of soybean agglutinin.
Three other proteins, including SBP, LEP, and sucrose-binding
protein, were identiﬁed as IgE binding proteins only among soy-sensi-
tized subjects. These IgE binding proteins are potential allergens, but
more work is required for veriﬁcation. Batista et al. identiﬁed LEP as a
potential allergen for soybean using similar techniques as those re-
ported here (Batista et al., 2007). Recently, SBP (Gly m 7) was puriﬁed
and conﬁrmed as a soybean allergen using peanut and soybean-allergic
human subjects (Riascos et al., 2016). The Gly m 7 protein description
has fulﬁlled the primary criteria of WHO/IUIS Allergen Nomenclature
Subcommittee and is included in the database. Sucrose binding protein
has also been identiﬁed as an IgE binding soy protein in 53% of thirty-
two North American soybean-allergic subjects in one study (Gagnon
et al., 2010).
Despite the large number (up to 21) of reported soybean allergens
(Selb et al., 2017; Wilson et al., 2005), their biological signiﬁcance and
immunologic characteristics have not been extensively studied com-
pared to the proteins in other allergenic foods, such as peanut. Many of
the reported soybean allergens were identiﬁed by serum IgE binding
using subjects with atopic dermatitis or sera from subjects whose soy-
bean food allergy was not conﬁrmed by controlled food challenge
(Hiemori et al., 2004; Ogawa et al., 1991, 1993; Tsuji et al., 1997). The
15 potential soybean allergens list in the OECD soybean consensus
document on compositional considerations for new GE varieties of
soybean includes Gly m 1, Gly m 2, Gly m 3, Gly m 4, Gly m 5, Gly m 6,
Gly m Bd 30 K, Gly m Bd 28 K, Gly m 8, SKTI, soybean lectin, lipox-
ygenase, and three uncharacterized proteins (50 kDa, 39 kDa, and P22-
25 proteins) (OECD, 2012).
Hydrophobic soybean hull protein Gly m 1 and the soybean hull
defensin Gly m 2 were not detected in this study, as expected, because
these two soy-hull proteins are airborne allergens (i.e., atmospheric
soybean dust) and only relevant to respiratory allergy. The short pep-
tides of Gly m 1 and Gly m 2 were identiﬁed as belonging to proteins
from studies of the Barcelona, Spain asthma epidemic near the port
facility in the 1980s (Hernando et al., 1989; Sunyer et al., 1989). The
sequence of Gly m 2 was unknown except that recent cloning studies
matched the peptide to a full-length protein sequence. The clinical re-
levance of these two soy-hull proteins is unknown.
The soybean proﬁlin Gly m 3 and the pathogenesis-related class 10
protein Gly m 4 are important IgE binding (cross-reactive) proteins for
some European soybean and birch pollen allergic subjects who typically
experience oral allergy syndrome when ingesting soybeans (Jenkins
et al., 2005; Mittag et al., 2004). However, the clinical relevance of Gly
m 3 and Gly m 4 as important allergens is limited geographically cor-
responding to areas where birch pollen allergy is common. Little evi-
dence supports their allergenicity in foods. Detecting IgE binding to
proﬁlin Gly m 3 depends on the integrity of a conformational epitopes
(Rihs et al., 1999). The 2-DE procedure used in this study probably
disrupted the integrity of the conformational epitopes of Gly m 3. In
addition, since Gly m 3 requires the full-length, correctly folded protein
to bind IgE, it is not likely to be a major allergen in cooked or processed
soy products. Interestingly Gly m 4, also known as starvation-asso-
ciated-message 22 (SAM) is> 50% identical to the Bet v 1 family of
birch pollen allergens and seems to initially be due to cross-reactivity.
The primary reports of clinical food allergy related to Gly m 4 are
subjects who were consuming large quantities of a nutritional lightly
processed food supplement (Kleine-Tebbe et al., 2002). Gly m 4 was not
detected by IgE binding in this study even though the serum Neb-7 has
a Gly m 4 speciﬁc IgE ImmunoCAP® value of 26.2 kU/l (Table 1). It is
possible that the protein is relatively easy to denature, and conforma-
tional epitopes of Gly m 4 might not be present in a 2-DE immunoblot.
Although the newly described 2S albumin of soybean (Gly m 8) was
reported to be an important as a biomarker for clinically severe food to
soybean for populations in Japan and Netherlands (Ebisawa et al.,
2013; Klemans et al., 2013) we did not detect IgE binding to it. There
seems to be little evidence that supports the importance of Gly m 4 or
Gly m 8 outside of the subjects from restricted geographies.
The other seven OECD listed putative soybean allergens (Gly m Bd
28 K, Gly m Bd 30 K, lectin, lipoxygenase, P22-25, unknown 39 kDa,
and unknown 50 kDa) were poorly characterized in published scientiﬁc
literature, and are they were not detected in our study. There is in-
suﬃcient evidence to suggest they cause soybean food allergy. Gly m Bd
28 K and 30 K were reported to be strong and frequent allergens in the
1990s in Japan; however, the IgE binding to the two allergens were
identiﬁed in the population of atopic dermatitis patients who had de-
tectable IgE to soybean tested by either radioallergosorbent assay or
SPT (Bando et al., 1996; Helm et al., 2000; Ogawa et al., 1993; Tsuji
et al., 1997). No food challenge or other convincing proof of soybean
allergies were reported in those studies. Thus, further evidence is
needed to classify Gly m Bd 28 K and Gly m Bd 30 K as conﬁrmed food
allergens. Only one peer-reviewed publication indicated that soybean
lectin and lipoxygenase are potential allergens for bakers suﬀering from
respiratory symptoms to soybean (Baur et al., 1996), however a recent
review suggested that those authors likely used an impure test sub-
stance (Ladics et al., 2014). The sequences and characteristics of three
proteins; P22-25, 39 kDa and 50 kDa remain unknown and it is not clear
why they have been listed by the OECD as allergens of soybean (Ladics
et al., 2014).
5. Conclusion
Current evidence suggests that the soybean proteins responsible for
food allergy are the major seed storage proteins, β-conglycinin (Gly m
5, with three subunits) and glycinin (Gly m 6, with ﬁve subunits), and
possibly SKTI. The prevalence and importance of other proteins in
soybean food allergy have not been conclusively demonstrated.
Carefully designed and performed studies are needed with isolated and
puriﬁed potential soy allergenic proteins to be tested in individuals
with clear evidence of allergic reactions to soy following oral challenge,
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especially DBPCFC, to expand the list for food safety concerns. Thus,
recommendations by the European Food Safety Authority for quanti-
tative analysis of all the OECD listed soy “allergens” for evaluation of
the safety of new GE soybeans is not justiﬁed in our opinion.
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